Delirium
617
59
82
315
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
59 trials with published results (10%)
Research Maturity
315 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.6%
41 terminated out of 617 trials
88.5%
+1.9% vs benchmark
16%
101 trials in Phase 3/4
19%
59 of 315 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 315 completed trials
Clinical Trials (617)
CTSN Embolic Protection Trial
Behavioral Economic & Staffing Strategies in the ICU
Neurosteer Bedside Monitoring System
Sleep Harmonization Via Bundled Team-Based Interventions in the ICU
Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle
pEEG Monitoring Effect on Delirium, Ventilator Days, and PICS
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
Dexmedetomidine Medication Records and Delirium After Coronary Artery Bypass Grafting
Light and Noise: Objectively Assessing Environmental Risk Factors for Delirium in the ICU
CITADEL: Effectiveness of CITicoline in Preventing Cognitive Decline After DELirium
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Intraoperative Midazolam on Delirium Outcome of Elderly Patients
A Study for Postoperative Delirium in Older Patients With Intracranial Tumors
DElirium and LIGHT: Exploring Modifiable Risk Factors of Delirium - a Pilot Study
Bedside Bike Early Mobilization Program for Inpatients
Multi-Component Delirium Prevention Bundle in Older Cardiac Intensive Care Unit Patients
Wearable Sensors for Delirium Detection at an Early Stage (WeSen_delirium)
PupillOmetry for Prediction of DelirIUM